Complex tissue-specific patterns and distribution of multiple RAGE splice variants in different mammals

Genome Biology and Evolution

Volumn 5, Issue 12, 2013, Pages 2420-2435

  López Díez, Raquel ^a   Rastrojo, Alberto ^a   Villate, Olatz ^b   Aguado, Begoña ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

AGER; Alternative splicing; Comparative genomics; mRNA isoforms; Noncoding RNA; RAGE

Indexed keywords

ADVANCED GLYCOSYLATION END PRODUCT RECEPTOR; ADVANCED GLYCOSYLATION END-PRODUCT RECEPTOR; IMMUNOGLOBULIN RECEPTOR; ISOPROTEIN; MESSENGER RNA; RNA ISOFORM; UNTRANSLATED RNA;

AGER; ALTERNATIVE RNA SPLICING; AMINO ACID SEQUENCE; ANIMAL; ANTIBODY SPECIFICITY; ARTICLE; CATTLE; COMPARATIVE GENOMICS; GENETIC VARIABILITY; GENETICS; HAPLORHINI; HUMAN; METABOLISM; MOUSE; NUCLEOTIDE SEQUENCE; RAGE; RAT; SIGNAL TRANSDUCTION; SPECIES DIFFERENCE; SWINE; TISSUE DISTRIBUTION;

AGER; ALTERNATIVE SPLICING; COMPARATIVE GENOMICS; MRNA ISOFORMS; NONCODING RNA; RAGE;

ALTERNATIVE SPLICING; AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; CATTLE; GENETIC VARIATION; HAPLORHINI; HUMANS; MICE; ORGAN SPECIFICITY; PROTEIN ISOFORMS; RATS; RECEPTORS, IMMUNOLOGIC; RNA, MESSENGER; RNA, UNTRANSLATED; SIGNAL TRANSDUCTION; SPECIES SPECIFICITY; SWINE; TISSUE DISTRIBUTION;

EID: 84892503373     PISSN: None     EISSN: 17596653     Source Type: Journal    
DOI: 10.1093/gbe/evt188     Document Type: Article

References (68)

1. Baek D, Green P. 2005. Sequence conservation, relative isoform frequencies, and nonsense-mediated decay in evolutionarily conserved alternative splicing. Proc Natl Acad Sci U S A. 102: 12813-12818.
2. Barbosa-Morais NL, et al. 2012. The evolutionary landscape of alternative splicing in vertebrate species. Science 338:1587-1593.
3. Blencowe BJ. 2006. Alternative splicing: new insights from global analyses. Cell 126:37-47.
4. Calarco JA, Zhen M, Blencowe BJ. 2011. Networking in a global world: establishing functional connections between neural splicing regulators and their target transcripts. RNA 17:775-791.
5. Calarco JA, et al. 2007. Global analysis of alternative splicing differences between humans and chimpanzees. Genes Dev. 21:2963-2975.
6. Colak R, et al. 2013. Distinct types of disorder in the human proteome: functional implications for alternative splicing. PLoS Comput Biol. 9: e1003030.
7. Cooper TA, Wan L, Dreyfuss G. 2009. RNA and disease. Cell 136: 777-793.
8. Ding Q, Keller JN. 2005a. Evaluation of rage isoforms, ligands, and signaling in the brain. Biochim Biophys Acta. 1746:18-27.
9. Ding Q, Keller JN. 2005b. Splice variants of the receptor for advanced glycosylation end products (RAGE) in human brain. Neurosci Lett. 373:67-72.
10. Duret L, Chureau C, Samain S, Weissenbach J, Avner P. 2006. The Xist RNA gene evolved in eutherians by pseudogenization of a proteincoding gene. Science 312:1653-1655.
11. Emanuele E, et al. 2005. Circulating levels of soluble receptor for advanced glycation end products in Alzheimer disease and vascular dementia. Arch Neurol. 62:1734-1736.
12. Falcone C, et al. 2005. Plasma levels of soluble receptor for advanced glycation end products and coronary artery disease in nondiabetic men. Arterioscler Thromb Vasc Biol. 25:1032-1037.
13. Geroldi D, et al. 2005. Decreased plasma levels of soluble receptor for advanced glycation end-products in patients with essential hypertension. J Hypertens. 23:1725-1729.
14. Ghavami S, et al. 2008. S100A8/A9 at low concentration promotes tumor cell growth via RAGE ligation and MAP kinase-dependent pathway. J Leukoc Biol. 83:1484-1492.
15. Gingeras TR. 2007. Origin of phenotypes: genes and transcripts. Genome Res. 17:682-690.
16. Goh SY, CooperME. 2008. Clinical review: the role of advanced glycation end products in progression and complications of diabetes. J Clin Endocrinol Metab. 93:1143-1152.
17. Grossin N, Wautier MP, Picot J, Stern DM, Wautier JL. 2009. Differential effect of plasma or erythrocyte AGE-ligands of RAGE on expression of transcripts for receptor isoforms. Diabetes Metab. 35:410-417.
18. Grossin N, et al. 2008. Severity of diabetic microvascular complications is associated with a low soluble RAGE level. Diabetes Metab. 34: 392-395.
19. Hanford LE, et al. 2004. Purification and characterization of mouse soluble receptor for advanced glycation end products (sRAGE). J Biol Chem. 279:50019-50024.
20. Harashima A, et al. 2006. Identification of mouse orthologue of endogenous secretory receptor for advanced glycation end-products: structure, function and expression. Biochem J. 396:109-115.
21. Harja E, et al. 2008. Vascular and inflammatory stresses mediate atherosclerosis via RAGE and its ligands in apoE-/-mice. J Clin Invest. 118: 183-194.
22. Hiwatashi K, et al. 2008. A novel function of the receptor for advanced glycation end-products (RAGE) in association with tumorigenesis and tumor differentiation of HCC. Ann Surg Oncol. 15:923-933.
23. HofmannMA, et al. 1999. RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides. Cell 97: 889-901.
24. Hori O, et al. 1995. The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin. Mediation of neurite outgrowth and co-expression of rage and amphoterin in the developing nervous system. J Biol Chem. 270:25752-25761.
25. Hudson BI, et al. 2008. Identification, classification, and expression of RAGE gene splice variants. FASEB J. 22:1572-1580.
26. Huttunen HJ, Fages C, Rauvala H. 1999. Receptor for advanced glycation end products (RAGE)-mediated neurite outgrowth and activation of NF-kappaB require the cytoplasmic domain of the receptor but different downstream signaling pathways. J Biol Chem. 274:19919-19924.
27. Irimia M, Blencowe BJ. 2012. Alternative splicing: decoding an expansive regulatory layer. Curr Opin Cell Biol. 24:323-332.
28. Kalea AZ, Schmidt AM, Hudson BI. 2011. Alternative splicing of RAGE: roles in biology and disease. Front Biosci. 17:2756-2770.
29. Kalea AZ, et al. 2009. Alternative splicing of the murine receptor for advanced glycation end-products (RAGE) gene. FASEB J. 23:1766-1774.
30. Kikuchi K, et al. 2009. Transcripts of unknown function in multiple-signaling pathways involved in human stem cell differentiation. Nucleic Acids Res. 37:4987-5000.
31. Kislinger T, et al. 1999. N(epsilon)-(carboxymethyl)lysine adducts of proteins are ligands for receptor for advanced glycation end products that activate cell signaling pathways and modulate gene expression. J Biol Chem. 274:31740-31749.
32. Langmead B, Trapnell C, PopM, Salzberg SL. 2009. Ultrafast andmemoryefficient alignment of short DNA sequences to the human genome. Genome Biol. 10:R25.
33. Li H, et al. 2009. The Sequence Alignment/Map format and SAMtools. Bioinformatics 25:2078-2079.
34. Licatalosi DD, Darnell RB. 2009. RNA processing and its regulation: global insights into biological networks. Nat Rev Genet. 11:75-87.
35. Lizotte PP, et al. 2007. Developmental expression of the receptor for advanced glycation end-products (RAGE) and its response to hyperoxia in the neonatal rat lung. BMC Dev Biol. 7:15.
36. Lynch KW. 2004. Consequences of regulated pre-mRNA splicing in the immune system. Nat Rev Immunol. 4:931-940.
37. Maillard-Lefebvre H, et al. 2009. Soluble receptor for advanced glycation end products: a new biomarker in diagnosis and prognosis of chronic inflammatory diseases. Rheumatology 48:1190-1196.
38. Malherbe P, et al. 1999. cDNA cloning of a novel secreted isoform of the human receptor for advanced glycation end products and characterization of cells co-expressing cell-surface scavenger receptors and Swedish mutant amyloid precursor protein. Brain Res Mol Brain Res. 71:159-170.
39. Marques AC, Ponting CP. 2009. Catalogues of mammalian long noncoding RNAs:modest conservation and incompleteness. Genome Biol. 10: R124.
40. McManus CJ, Graveley BR. 2011. RNA structure and the mechanisms of alternative splicing. Curr Opin Genet Dev. 21:373-379.
41. Melamud E, Moult J. 2009. Stochastic noise in splicing machinery. Nucleic Acids Res. 37:4873-4886.
42. Mercer TR, et al. 2011. Targeted RNA sequencing reveals the deep complexity of the human transcriptome. Nat Biotechnol. 30:99-104.
43. Merkin J, Russell C, Chen P, Burge CB. 2012. Evolutionary dynamics of gene and isoform regulation in Mammalian tissues. Science 338: 1593-1599.
44. Neeper M, et al. 1992. Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins. J Biol Chem. 267: 14998-15004.
45. Nilsen TW, Graveley BR. 2010. Expansion of the eukaryotic proteome by alternative splicing. Nature 463:457-463.
46. Nurtdinov RN, Neverov AD, Favorov AV, Mironov AA, Gelfand MS. 2007. Conserved and species-specific alternative splicing in mammalian genomes. BMC Evol Biol. 7:249.
47. Pan Q, Shai O, Lee LJ, Frey BJ, Blencowe BJ. 2008. Deep surveying of alternative splicing complexity in the human transcriptome by highthroughput sequencing. Nat Genet. 40:1413-1415.
48. Pan Q, et al. 2005. Alternative splicing of conserved exons is frequently species-specific in human and mouse. Trends Genet. 21:73-77.
49. Pickrell JK, Pai AA, Gilad Y, Pritchard JK. 2010. Noisy splicing drives mRNA isoform diversity in human cells. PLoS Genet. 6:e1001236.
50. Ponting CP, Oliver PL, Reik W. 2009. Evolution and functions of long noncoding RNAs. Cell 136:629-641.
51. Rastrojo A, et al. 2013. The transcriptome of Leishmania major in the axenic promastigote stage: transcript annotation and relative expression levels by RNA-seq. BMC Genomics 14:223.
52. Raucci A, et al. 2008. A soluble form of the receptor for advanced glycation endproducts (RAGE) is produced by proteolytic cleavage of the membrane-bound form by the sheddase a disintegrin and metalloprotease 10 (ADAM10). FASEB J. 22:3716-3727.
53. Rinn JL, et al. 2007. Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs. Cell 129: 1311-1323.
54. Robinson JT, et al. 2011. Integrative genomics viewer. Nat Biotechnol. 29: 24-26.
55. Sinkora M, Butler JE, Holtmeier W, Sinkorova J. 2005. Lymphocyte development in fetal piglets: facts and surprises. Vet Immunol Immunopathol. 108:177-184.
56. Sterenczak KA, Nolte I, Murua Escobar H. 2013. RAGE splicing variants in mammals. Methods Mol Biol. 963:265-276.
57. Sterenczak KA, et al. 2009. Cloning, characterisation, and comparative quantitative expression analyses of receptor for advanced glycation end products (RAGE) transcript forms. Gene 434:35-42.
58. Trapnell C, Pachter L, Salzberg SL. 2009. TopHat: discovering splice junctions with RNA-Seq. Bioinformatics 25:1105-1111.
59. Trapnell C, et al. 2010. Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. Nat Biotechnol. 28:511-515.
60. Tuck AC, Tollervey D. 2011. RNA in pieces. Trends Genet. 27:422-432.
61. Villate O, Rastrojo A, Lopez-Diez R, Hernandez-Torres F, Aguado B. 2008. Differential splicing, disease and drug targets. Infect Disord Drug Targets. 8:241-251.
62. Xing Y, Lee C. 2005. Evidence of functional selection pressure for alternative splicing events that accelerate evolution of protein subsequences. Proc Natl Acad Sci U S A. 102:13526-13531.
63. Xing Y, Lee C. 2007. Relating alternative splicing to proteome complexity and genome evolution. Adv Exp Med Biol. 623:36-49.
64. Yan SD, et al. 1996. RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease. Nature 382:685-691.
65. Yang Y, et al. 2011. RNA secondary structure inmutually exclusive splicing. Nat Struct Mol Biol. 18:159-168.
66. Yonekura H, et al. 2003. Novel splice variants of the receptor for advanced glycation end-products expressed in human vascular endothelial cells and pericytes, and their putative roles in diabetes-induced vascular injury. Biochem J. 370:1097-1109.
67. Zhang C, Krainer AR, Zhang MQ. 2007. Evolutionary impact of limited splicing fidelity in mammalian genes. Trends Genet. 23:484-488.
68. Zhang Z, et al. 2009. Noisy splicing, more than expression regulation, explains why some exons are subject to nonsense-mediated mRNA decay. BMC Biol. 7:23.